-
Judge Dismisses Republican Group’s Case Against the University of Florida
A campus group the university banned after accusations of antisemitic behavior failed to prove it had its First Amendment rights violated, the court ruled.
-
How AI is Quietly Reshaping Everyday Decision-Making
There was a time not too long ago when artificial intelligence felt like a distant, futuristic concept. It was the stuff of science fiction movies and tech conferences, something to be marveled at from afar. Yet today, AI has quietly seeped into the nooks and crannies of our daily lives, gently nudging, suggesting, and guiding…
-
Recent Federal Developments Targeting China-Linked Companies and Overseas Biotechnology Investments and Collaboration
In recent weeks, Congress and the Administration have escalated scrutiny of China-linked biotechnology, pharmaceutical development, and related intellectual property. The developments below signal that the landscape for companies with China-linked operations, partnerships, or investments is shifting rapidly and warrants close monitoring and active planning….By: Foley Hoag LLP
-
Hikma Pharmaceutical USA Inc. v. Amarin Pharma Inc.
In a unanimous decision of June 4, 2026 in Hikma Pharmaceutical USA Inc. v. Amarin Pharma Inc., authored by Justice Jackson, the Supreme Court clarified the pleading requirements for claims of induced patent infringement when a generic drug manufacturer receives approval to market a drug for a nonpatented use while other uses of the drug…
-
Supreme Court Finds No Plausible Allegations of Induced Infringement Through Generic Pharmaceutical Manufacturer’s Label and Statements
In the recent ruling in Hikma Pharmaceuticals v. Amarin Pharma, No. 24–889., the U.S. Supreme Court applied its pleading standards established in the Twombly and Iqbal line of cases and unanimously held plaintiff, Amarin Pharma, had not satisfied these standards with respect to its claim for induced infringement under 35 U.S.C. § 271(b). The Supreme…
-
Patent Case Summaries | Week Ending June 5, 2026
Our Patent Case Summaries provide a weekly summary of the precedential patent-related opinions issued by the Court of Appeals for the Federal Circuit and the opinions designated precedential or informative by the Patent Trial and Appeal Board….By: Alston & Bird
-
CMMC Assessments and the Hidden Risk of ITAR Violations
For many contractors within the Defense Industrial Base, Cybersecurity Maturity Model Certification (CMMC) assessments are becoming far more than cybersecurity hygiene exercises. As companies strive to become CMMC compliant, they are increasingly uncovering facts suggesting potential violations of export control laws, including the International Traffic in Arms Regulations (ITAR), administered by the Directorate of Defense…
-
Federal Rule 50’s Two-Step: A Costly Lesson for Federal Civil Litigators
Nelson v. Toyota Motor Corporation, No. 24-1408 (10th Cir. June 1, 2026) is a stark reminder that in federal civil litigation, procedural compliance with Federal Rule of Civil Procedure 50 is not a technicality. It is a prerequisite to appellate review for sufficiency of the evidence, and no amount of substantive briefing can substitute for…
-
Iran War Live Updates: Cease-Fire Deal Appears Within Reach, Officials Say
U.S. and Iranian officials said final details were still being worked out, but President Trump and Iran’s foreign minister both said they were close to an agreement. Previous potential deals have evaporated at the last minute.
-
U.S. Plan Is Said to Pull a Third of Fighter Jets It Provides NATO for Europe
The plan, outlined by officials and in a written document, provides rare clarity about the extent to which the Trump administration intends to reduce its commitment to NATO.
